Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEPUS: Daratumumab (DVd) vs Vd in Chinese RRMM
NCT03234972Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2017
- Primary completion
- Oct 2019
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of daratumumab in multiple myeloma (MM), sponsored by Janssen Pharmaceutical. Started Nov 2017; status: completed.
02
Drugs
daratumumab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03234972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03234972.